A Clinical and Animal Experiment Integrated Platform for Small-Molecule Screening Reveals Potential Targets of Bioactive Compounds from a Herbal Prescription Based on the Therapeutic Efficacy of Yinchenhao Tang for Jaundice Syndrome

A herbal prescription in traditional Chinese medicine (TCM) has great complexity, with multiple components and multiple targets, making it extremely challenging to determine its bioactive compounds. Yinchenhao Tang (YCHT) has been extensively used for the treatment of jaundice disease. Although many...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hui Xiong, Ai-Hua Zhang, Ya-Jing Guo, Xiao-Hang Zhou, Hui Sun, Le Yang, Heng Fang, Guang-Li Yan, Xi-Jun Wang
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://doaj.org/article/38538fe076fe48908e9167586e4c8ed5
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:38538fe076fe48908e9167586e4c8ed5
record_format dspace
spelling oai:doaj.org-article:38538fe076fe48908e9167586e4c8ed52021-11-14T04:32:12ZA Clinical and Animal Experiment Integrated Platform for Small-Molecule Screening Reveals Potential Targets of Bioactive Compounds from a Herbal Prescription Based on the Therapeutic Efficacy of Yinchenhao Tang for Jaundice Syndrome2095-809910.1016/j.eng.2020.12.016https://doaj.org/article/38538fe076fe48908e9167586e4c8ed52021-09-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2095809921000527https://doaj.org/toc/2095-8099A herbal prescription in traditional Chinese medicine (TCM) has great complexity, with multiple components and multiple targets, making it extremely challenging to determine its bioactive compounds. Yinchenhao Tang (YCHT) has been extensively used for the treatment of jaundice disease. Although many studies have examined the efficacy and active ingredients of YCHT, there is still a lack of an in-depth systematic analysis of its effective components, mechanisms, and potential targets—especially one based on clinical patients. This study established an innovative strategy for discovering the potential targets and active compounds of YCHT based on an integrated clinical and animal experiment platform. The serum metabolic profiles and constituents of YCHT in vivo were determined by ultra-performance liquid chromatography–quadrupole time-of-flight mass spectrometry (UPLC-Q-ToF-MS)-based metabolomics combined with a serum pharmacochemistry method. Moreover, a compound–target–pathway network was constructed and analyzed by network pharmacology and ingenuity pathway analysis (IPA). We found that eight active components could modulate five key targets. These key targets were further verified by enzyme-linked immunosorbent assay (ELISA), which indicated that YCHT exerts therapeutic effects by targeting cholesterol 7α-hydroxylase (CYP7A1), multidrug-resistance-associated protein 2 (ABCC2), multidrug-resistance-associated protein 3 (ABCC3), uridine diphosphate glucuronosyl transferase 1A1 (UGT1A1), and farnesoid X receptor (FXR), and by regulating metabolic pathways including primary bile acid biosynthesis, porphyrin and chlorophyll metabolism, and biliary secretion. Eight main effective compounds were discovered and correlated with the key targets and pathways. In this way, we demonstrate that this integrated strategy can be successfully applied for the effective discovery of the active compounds and therapeutic targets of an herbal prescription.Hui XiongAi-Hua ZhangYa-Jing GuoXiao-Hang ZhouHui SunLe YangHeng FangGuang-Li YanXi-Jun WangElsevierarticleEfficacyBioactive compoundSmall moleculeTargetsHerbal medicineMetabolomicsEngineering (General). Civil engineering (General)TA1-2040ENEngineering, Vol 7, Iss 9, Pp 1293-1305 (2021)
institution DOAJ
collection DOAJ
language EN
topic Efficacy
Bioactive compound
Small molecule
Targets
Herbal medicine
Metabolomics
Engineering (General). Civil engineering (General)
TA1-2040
spellingShingle Efficacy
Bioactive compound
Small molecule
Targets
Herbal medicine
Metabolomics
Engineering (General). Civil engineering (General)
TA1-2040
Hui Xiong
Ai-Hua Zhang
Ya-Jing Guo
Xiao-Hang Zhou
Hui Sun
Le Yang
Heng Fang
Guang-Li Yan
Xi-Jun Wang
A Clinical and Animal Experiment Integrated Platform for Small-Molecule Screening Reveals Potential Targets of Bioactive Compounds from a Herbal Prescription Based on the Therapeutic Efficacy of Yinchenhao Tang for Jaundice Syndrome
description A herbal prescription in traditional Chinese medicine (TCM) has great complexity, with multiple components and multiple targets, making it extremely challenging to determine its bioactive compounds. Yinchenhao Tang (YCHT) has been extensively used for the treatment of jaundice disease. Although many studies have examined the efficacy and active ingredients of YCHT, there is still a lack of an in-depth systematic analysis of its effective components, mechanisms, and potential targets—especially one based on clinical patients. This study established an innovative strategy for discovering the potential targets and active compounds of YCHT based on an integrated clinical and animal experiment platform. The serum metabolic profiles and constituents of YCHT in vivo were determined by ultra-performance liquid chromatography–quadrupole time-of-flight mass spectrometry (UPLC-Q-ToF-MS)-based metabolomics combined with a serum pharmacochemistry method. Moreover, a compound–target–pathway network was constructed and analyzed by network pharmacology and ingenuity pathway analysis (IPA). We found that eight active components could modulate five key targets. These key targets were further verified by enzyme-linked immunosorbent assay (ELISA), which indicated that YCHT exerts therapeutic effects by targeting cholesterol 7α-hydroxylase (CYP7A1), multidrug-resistance-associated protein 2 (ABCC2), multidrug-resistance-associated protein 3 (ABCC3), uridine diphosphate glucuronosyl transferase 1A1 (UGT1A1), and farnesoid X receptor (FXR), and by regulating metabolic pathways including primary bile acid biosynthesis, porphyrin and chlorophyll metabolism, and biliary secretion. Eight main effective compounds were discovered and correlated with the key targets and pathways. In this way, we demonstrate that this integrated strategy can be successfully applied for the effective discovery of the active compounds and therapeutic targets of an herbal prescription.
format article
author Hui Xiong
Ai-Hua Zhang
Ya-Jing Guo
Xiao-Hang Zhou
Hui Sun
Le Yang
Heng Fang
Guang-Li Yan
Xi-Jun Wang
author_facet Hui Xiong
Ai-Hua Zhang
Ya-Jing Guo
Xiao-Hang Zhou
Hui Sun
Le Yang
Heng Fang
Guang-Li Yan
Xi-Jun Wang
author_sort Hui Xiong
title A Clinical and Animal Experiment Integrated Platform for Small-Molecule Screening Reveals Potential Targets of Bioactive Compounds from a Herbal Prescription Based on the Therapeutic Efficacy of Yinchenhao Tang for Jaundice Syndrome
title_short A Clinical and Animal Experiment Integrated Platform for Small-Molecule Screening Reveals Potential Targets of Bioactive Compounds from a Herbal Prescription Based on the Therapeutic Efficacy of Yinchenhao Tang for Jaundice Syndrome
title_full A Clinical and Animal Experiment Integrated Platform for Small-Molecule Screening Reveals Potential Targets of Bioactive Compounds from a Herbal Prescription Based on the Therapeutic Efficacy of Yinchenhao Tang for Jaundice Syndrome
title_fullStr A Clinical and Animal Experiment Integrated Platform for Small-Molecule Screening Reveals Potential Targets of Bioactive Compounds from a Herbal Prescription Based on the Therapeutic Efficacy of Yinchenhao Tang for Jaundice Syndrome
title_full_unstemmed A Clinical and Animal Experiment Integrated Platform for Small-Molecule Screening Reveals Potential Targets of Bioactive Compounds from a Herbal Prescription Based on the Therapeutic Efficacy of Yinchenhao Tang for Jaundice Syndrome
title_sort clinical and animal experiment integrated platform for small-molecule screening reveals potential targets of bioactive compounds from a herbal prescription based on the therapeutic efficacy of yinchenhao tang for jaundice syndrome
publisher Elsevier
publishDate 2021
url https://doaj.org/article/38538fe076fe48908e9167586e4c8ed5
work_keys_str_mv AT huixiong aclinicalandanimalexperimentintegratedplatformforsmallmoleculescreeningrevealspotentialtargetsofbioactivecompoundsfromaherbalprescriptionbasedonthetherapeuticefficacyofyinchenhaotangforjaundicesyndrome
AT aihuazhang aclinicalandanimalexperimentintegratedplatformforsmallmoleculescreeningrevealspotentialtargetsofbioactivecompoundsfromaherbalprescriptionbasedonthetherapeuticefficacyofyinchenhaotangforjaundicesyndrome
AT yajingguo aclinicalandanimalexperimentintegratedplatformforsmallmoleculescreeningrevealspotentialtargetsofbioactivecompoundsfromaherbalprescriptionbasedonthetherapeuticefficacyofyinchenhaotangforjaundicesyndrome
AT xiaohangzhou aclinicalandanimalexperimentintegratedplatformforsmallmoleculescreeningrevealspotentialtargetsofbioactivecompoundsfromaherbalprescriptionbasedonthetherapeuticefficacyofyinchenhaotangforjaundicesyndrome
AT huisun aclinicalandanimalexperimentintegratedplatformforsmallmoleculescreeningrevealspotentialtargetsofbioactivecompoundsfromaherbalprescriptionbasedonthetherapeuticefficacyofyinchenhaotangforjaundicesyndrome
AT leyang aclinicalandanimalexperimentintegratedplatformforsmallmoleculescreeningrevealspotentialtargetsofbioactivecompoundsfromaherbalprescriptionbasedonthetherapeuticefficacyofyinchenhaotangforjaundicesyndrome
AT hengfang aclinicalandanimalexperimentintegratedplatformforsmallmoleculescreeningrevealspotentialtargetsofbioactivecompoundsfromaherbalprescriptionbasedonthetherapeuticefficacyofyinchenhaotangforjaundicesyndrome
AT guangliyan aclinicalandanimalexperimentintegratedplatformforsmallmoleculescreeningrevealspotentialtargetsofbioactivecompoundsfromaherbalprescriptionbasedonthetherapeuticefficacyofyinchenhaotangforjaundicesyndrome
AT xijunwang aclinicalandanimalexperimentintegratedplatformforsmallmoleculescreeningrevealspotentialtargetsofbioactivecompoundsfromaherbalprescriptionbasedonthetherapeuticefficacyofyinchenhaotangforjaundicesyndrome
AT huixiong clinicalandanimalexperimentintegratedplatformforsmallmoleculescreeningrevealspotentialtargetsofbioactivecompoundsfromaherbalprescriptionbasedonthetherapeuticefficacyofyinchenhaotangforjaundicesyndrome
AT aihuazhang clinicalandanimalexperimentintegratedplatformforsmallmoleculescreeningrevealspotentialtargetsofbioactivecompoundsfromaherbalprescriptionbasedonthetherapeuticefficacyofyinchenhaotangforjaundicesyndrome
AT yajingguo clinicalandanimalexperimentintegratedplatformforsmallmoleculescreeningrevealspotentialtargetsofbioactivecompoundsfromaherbalprescriptionbasedonthetherapeuticefficacyofyinchenhaotangforjaundicesyndrome
AT xiaohangzhou clinicalandanimalexperimentintegratedplatformforsmallmoleculescreeningrevealspotentialtargetsofbioactivecompoundsfromaherbalprescriptionbasedonthetherapeuticefficacyofyinchenhaotangforjaundicesyndrome
AT huisun clinicalandanimalexperimentintegratedplatformforsmallmoleculescreeningrevealspotentialtargetsofbioactivecompoundsfromaherbalprescriptionbasedonthetherapeuticefficacyofyinchenhaotangforjaundicesyndrome
AT leyang clinicalandanimalexperimentintegratedplatformforsmallmoleculescreeningrevealspotentialtargetsofbioactivecompoundsfromaherbalprescriptionbasedonthetherapeuticefficacyofyinchenhaotangforjaundicesyndrome
AT hengfang clinicalandanimalexperimentintegratedplatformforsmallmoleculescreeningrevealspotentialtargetsofbioactivecompoundsfromaherbalprescriptionbasedonthetherapeuticefficacyofyinchenhaotangforjaundicesyndrome
AT guangliyan clinicalandanimalexperimentintegratedplatformforsmallmoleculescreeningrevealspotentialtargetsofbioactivecompoundsfromaherbalprescriptionbasedonthetherapeuticefficacyofyinchenhaotangforjaundicesyndrome
AT xijunwang clinicalandanimalexperimentintegratedplatformforsmallmoleculescreeningrevealspotentialtargetsofbioactivecompoundsfromaherbalprescriptionbasedonthetherapeuticefficacyofyinchenhaotangforjaundicesyndrome
_version_ 1718429949934698496